The physiology and clinical utility of anti-Mullerian hormone in women (Q34398233)

1 August 2017

title

The physiology and clinical utility of anti-Mullerian hormone in women (English)

1 reference

1 August 2017

0 references

Claus Yding Andersen

1 reference

1 August 2017

W Hamish Wallace

1 reference

1 August 2017

Tom W Kelsey

0 references

Scott M Nelson

0 references

Antonio La Marca

0 references

Didier Dewailly

0 references

Frank Broekmans

1 reference

1 August 2017

Adam Balen

1 reference

1 August 2017

Nafi Dilaver

1 reference

1 August 2017

Renato Fanchin

1 reference

1 August 2017

Georg Griesinger

1 reference

1 August 2017

Cornelius Lambalk

1 reference

1 August 2017

Helen Mason

1 reference

1 August 2017

Jenny A Visser

1 reference

1 August 2017

Richard A Anderson

1 reference

1 August 2017

publication date

14 January 2014

1 reference

Human Reproduction Update

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

370-385

1 reference

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Maternal death related to IVF in the Netherlands 1984-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

The antral follicle count: practical recommendations for better standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Variants of the anti-Müllerian hormone gene in a compound heterozygote with the persistent Müllerian duct syndrome and his family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Testosterone-induced downregulation of anti-Müllerian hormone expression in granulosa cells from small bovine follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Smoking and AMH levels in women with normal reproductive history

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Regulation of ovarian function: the role of anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Association of anti-mullerian hormone levels with obesity in late reproductive-age women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Impact of cancer therapies on ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone remains highly expressed in human cumulus cells during the final stages of folliculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

An Enzyme Linked Immunoassay for Anti-Müllerian Hormone: A New Tool for the Evaluation of Testicular Function in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

A validated model of serum anti-müllerian hormone from conception to menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Data-driven assessment of the human ovarian reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian-hormone levels during pregnancy and postpartum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Genetics of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

The Anti-Mullerian hormone and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-Mullerian hormone throughout the human menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Age-specific nomogram for the decline in antral follicle count throughout the reproductive period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Correlation between three assay systems for anti-Müllerian hormone (AMH) determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Predicting Live Birth, Preterm Delivery, and Low Birth Weight in Infants Born from In Vitro Fertilisation: A Prospective Study of 144,018 Treatment Cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone initiates growth of human primordial follicles in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Antimullerian hormone and obesity: insights in oral contraceptive users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Impact of breast cancer on anti-mullerian hormone levels in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Modeling age at menopause using serum concentration of anti-mullerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone (AMH): regulator and marker of ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone and folliculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone: a new marker for ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Human studies on genetics of the age at natural menopause: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Human ovarian reserve from conception to the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Effect of cigarette smoking upon reproductive hormones in women of reproductive age: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Formation and early development of follicles in the polycystic ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Anti-Müllerian hormone levels and antral follicle count in women enrolled inin vitrofertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT062

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMT062

1 reference

release_wbpodsdpsfdvzjmkp6lk3aburq

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wbpodsdpsfdvzjmkp6lk3aburq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference